Advertisement

Topics

Generics, mergers and Teva’s woes: Agilent talks pharma opportunities

05:08 EST 15 Feb 2018 | in-PharmaTechnologis

Agilent Technologies says changes in the industry this year will present opportunities for continued growth in its pharma processing equipment and consumables business.

Original Article: Generics, mergers and Teva’s woes: Agilent talks pharma opportunities

NEXT ARTICLE

More From BioPortfolio on "Generics, mergers and Teva’s woes: Agilent talks pharma opportunities"

Advertisement
Quick Search
Advertisement
Advertisement